mRNA |
etomoxir |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.2 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.2 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.2 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.2 |
mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
linifanib |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.2 |
mRNA |
ELCPK |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.2 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.2 |
mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |